GC Biopharma Corp. (KRX:006280)
South Korea flag South Korea · Delayed Price · Currency is KRW
135,000
+1,800 (1.35%)
Nov 17, 2026, 3:30 PM KST

GC Biopharma Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, GC Biopharma stock has a consensus rating of "Buy" and an average price target of ₩192,250. The average 1-year stock price forecast is 42.41% higher than the current stock price, while the lowest is ₩165,000 (+22.22%) and the highest is ₩220,000 (+62.96%).

Price Target: ₩192,250 (+42.41%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₩165,000₩192,250₩197,500₩220,000
Change+22.22%+42.41%+46.30%+62.96%

Analyst Ratings

The average analyst rating for GC Biopharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Oct '26Nov '26
Strong Buy443333
Buy665555
Hold000000
Sell000000
Strong Sell000000
Total10108888

Financial Forecast

Revenue This Year
1.47T
from 1.99T
Decreased by -26.22%
Revenue Next Year
1.55T
from 1.47T
Increased by 5.20%
EPS This Year
17.29K
from -410.00
EPS Next Year
4.60K
from 17.29K
Decreased by -73.39%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.54T1.71T1.63T1.68T1.99T1.47T
Revenue Growth
2.24%11.28%-4.95%3.27%18.54%-26.22%
Gross Profit
519.24B579.96B483.33B480.54B552.64B464.24B
Gross Margin
33.76%33.89%29.71%28.61%27.75%31.60%
Operating Income
73.73B80.71B33.91B32.04B67.81B123.75B
Net Income
123.21B65.45B-26.63B-26.28B-4.67B173.50B
EPS
-----410.0017,290.16
Forward PE
25.0021.0947.3587.9928.997.81
Dividend / Share
----1,500.001,500.00
Free Cash Flow
----27.10B24.00B
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.

Revenue Forecast

Revenue202620272028
High1.9T
Avg1.5T
Low1.5T

Revenue Growth

Revenue Growth202620272028
High
-4.0%
Avg
-26.2%
Low
-26.2%

EPS Forecast

EPS202620272028
High24,387.00
Avg17,290.16
Low5,331.00

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-